E
Adicet Bio, Inc.
ACET
$0.671
-$0.053-7.32%
E
Sell
2/4/2025Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 2/4/2025 due to a decline in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 2/4/2025 due to a decline in the volatility index and total return index.
D
Sell
1/16/2025Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 1/16/2025 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 6.05% from -$23.42M to -$22.01M.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 1/16/2025 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 6.05% from -$23.42M to -$22.01M.
E
Sell
10/31/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 10/31/2024 due to a decline in the volatility index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 10/31/2024 due to a decline in the volatility index.
D
Sell
10/10/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 10/10/2024 due to an increase in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 10/10/2024 due to an increase in the total return index and volatility index.
E
Sell
9/23/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 9/23/2024 due to a decline in the volatility index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 9/23/2024 due to a decline in the volatility index.
D
Sell
9/5/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index and total return index.
E
Sell
8/19/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 8/19/2024 due to a decline in the volatility index, solvency index and growth index. The quick ratio declined from 14.18 to 12.52, EBIT declined 6.41% from -$30.87M to -$32.85M, and operating cash flow declined 2.51% from -$22.85M to -$23.42M.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 8/19/2024 due to a decline in the volatility index, solvency index and growth index. The quick ratio declined from 14.18 to 12.52, EBIT declined 6.41% from -$30.87M to -$32.85M, and operating cash flow declined 2.51% from -$22.85M to -$23.42M.
D
Sell
7/31/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 7/31/2024 due to an increase in the volatility index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 7/31/2024 due to an increase in the volatility index.
E
Sell
7/15/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 7/15/2024 due to a decline in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 7/15/2024 due to a decline in the volatility index and total return index.
D
Sell
6/25/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 6/25/2024 due to an increase in the volatility index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 6/25/2024 due to an increase in the volatility index.
E
Sell
6/6/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 6/6/2024 due to a decline in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 6/6/2024 due to a decline in the volatility index and total return index.
D
Sell
5/17/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 5/17/2024 due to a noticeable increase in the growth index, solvency index and volatility index. The quick ratio increased from 8.28 to 14.18, debt to equity declined from 0.02 to 0.01, and earnings per share increased from -$0.6852 to -$0.3543.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 5/17/2024 due to a noticeable increase in the growth index, solvency index and volatility index. The quick ratio increased from 8.28 to 14.18, debt to equity declined from 0.02 to 0.01, and earnings per share increased from -$0.6852 to -$0.3543.
E
Sell
5/2/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 5/2/2024 due to a decline in the volatility index, total return index and growth index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 5/2/2024 due to a decline in the volatility index, total return index and growth index.
D
Sell
4/12/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 4/12/2024 due to an increase in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 4/12/2024 due to an increase in the volatility index and total return index.
E
Sell
3/27/2024Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 3/27/2024 due to a decline in the volatility index and solvency index. The quick ratio declined from 9.27 to 8.28.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 3/27/2024 due to a decline in the volatility index and solvency index. The quick ratio declined from 9.27 to 8.28.
D
Sell
2/7/2024Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 2/7/2024 due to an increase in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 2/7/2024 due to an increase in the volatility index and total return index.
E
Sell
7/20/2023Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 7/20/2023 due to a decline in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 7/20/2023 due to a decline in the total return index and volatility index.
D
Sell
7/5/2023Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 7/5/2023 due to an increase in the volatility index and valuation index.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 7/5/2023 due to an increase in the volatility index and valuation index.
E
Sell
6/16/2023Downgrade
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 6/16/2023 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 27.91% from -$18.84M to -$24.09M, EBIT declined 5.57% from -$31.57M to -$33.32M, and earnings per share declined from -$0.7173 to -$0.72.
Adicet Bio, Inc. (ACET) was downgraded to E+ from D- on 6/16/2023 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 27.91% from -$18.84M to -$24.09M, EBIT declined 5.57% from -$31.57M to -$33.32M, and earnings per share declined from -$0.7173 to -$0.72.
D
Sell
3/14/2023Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 02/23/2023.
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
1/27/2023Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D from D+ on 1/27/2023 due to a major decline in the total return index, solvency index and volatility index.
Adicet Bio, Inc. (ACET) was downgraded to D from D+ on 1/27/2023 due to a major decline in the total return index, solvency index and volatility index.
D
Sell
10/13/2022Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D+ from D on 10/13/2022 due to a large increase in the total return index, volatility index and valuation index.
Adicet Bio, Inc. (ACET) was upgraded to D+ from D on 10/13/2022 due to a large increase in the total return index, volatility index and valuation index.
D
Sell
8/12/2022Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D from D+ on 8/12/2022 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $0.1 to -$0.5624, EBIT declined 582.51% from $4.71M to -$22.71M, and operating cash flow declined 458.22% from $4.11M to -$14.71M.
Adicet Bio, Inc. (ACET) was downgraded to D from D+ on 8/12/2022 due to a significant decline in the growth index, solvency index and valuation index. Earnings per share declined from $0.1 to -$0.5624, EBIT declined 582.51% from $4.71M to -$22.71M, and operating cash flow declined 458.22% from $4.11M to -$14.71M.
D
Sell
5/20/2022Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 5/20/2022 due to an increase in the valuation index.
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 5/20/2022 due to an increase in the valuation index.
D
Sell
5/13/2022Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 5/13/2022 due to a decline in the total return index and valuation index.
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 5/13/2022 due to a decline in the total return index and valuation index.
D
Sell
5/4/2022Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 5/4/2022 due to an increase in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 5/4/2022 due to an increase in the total return index and volatility index.
D
Sell
5/1/2022Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 5/1/2022 due to a decline in the total return index.
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 04/21/2022.
Adicet Bio, Inc. (ACET) was upgraded to D+ from D- on 04/21/2022.
D
Sell
4/20/2022Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 04/20/2022.
Adicet Bio, Inc. (ACET) was downgraded to D- from D+ on 04/20/2022.
D
Sell
4/18/2022Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D+ from D on 4/18/2022 due to a major increase in the total return index, growth index and volatility index. Total revenue increased 59.46% from $3.43M to $5.47M.
Adicet Bio, Inc. (ACET) was upgraded to D+ from D on 4/18/2022 due to a major increase in the total return index, growth index and volatility index. Total revenue increased 59.46% from $3.43M to $5.47M.
D
Sell
12/8/2021Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 12/8/2021 due to an increase in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 12/8/2021 due to an increase in the volatility index and total return index.
D
Sell
11/8/2021Downgrade
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 11/08/2021.
Adicet Bio, Inc. (ACET) was downgraded to D- from D on 11/08/2021.
D
Sell
10/1/2021Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 10/1/2021 due to a substantial increase in the growth index, solvency index and valuation index. Total revenue increased 220.92% from -$3.98M to $4.81M, debt to equity declined from 0.01 to 0, and earnings per share increased from -$0.8168 to -$0.3411.
Adicet Bio, Inc. (ACET) was upgraded to D from D- on 10/1/2021 due to a substantial increase in the growth index, solvency index and valuation index. Total revenue increased 220.92% from -$3.98M to $4.81M, debt to equity declined from 0.01 to 0, and earnings per share increased from -$0.8168 to -$0.3411.
D
Sell
6/1/2021Upgraded
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 6/1/2021 due to an increase in the solvency index and valuation index. The quick ratio increased from 4.33 to 8.87.
Adicet Bio, Inc. (ACET) was upgraded to D- from E+ on 6/1/2021 due to an increase in the solvency index and valuation index. The quick ratio increased from 4.33 to 8.87.
E
Sell
3/1/2021Upgraded
Adicet Bio, Inc. (ACET) was upgraded to E+ from E on 3/1/2021 due to an increase in the total return index and volatility index.
Adicet Bio, Inc. (ACET) was upgraded to E+ from E on 3/1/2021 due to an increase in the total return index and volatility index.
E
Sell
12/14/2020Upgraded
Adicet Bio, Inc. (ACET) was upgraded to E from E- on 12/14/2020 due to an increase in the volatility index and total return index.
Adicet Bio, Inc. (ACET) was upgraded to E from E- on 12/14/2020 due to an increase in the volatility index and total return index.
E
Sell
12/9/2020None
Adicet Bio, Inc. (ACET) was downgraded to E- from U on 12/09/2020.
Adicet Bio, Inc. (ACET) was downgraded to E- from U on 12/09/2020.
NASDAQ
04/03/2025 4:00PM Eastern
Quotes delayed
